1
项与 Autologous CD133+ Stem Cells(Miltenyi Biotec) 相关的临床试验Implantation of Autologous CD133+ Stem Cells in Patients Undergoing CABG
Following myocardial infarct, cellular therapy is a potential approach to repopulate the injured myocardium, to treat heart failure and restore cardiac function. The purpose of this study is to assess the safety, feasibility and efficacy of intramyocardial delivery of selected autologous CD133+ bone marrow stem cells at the time of coronary artery bypass grafting in patients with chronic ischemic cardiomyopathy.
100 项与 Autologous CD133+ Stem Cells(Miltenyi Biotec) 相关的临床结果
100 项与 Autologous CD133+ Stem Cells(Miltenyi Biotec) 相关的转化医学
100 项与 Autologous CD133+ Stem Cells(Miltenyi Biotec) 相关的专利(医药)
100 项与 Autologous CD133+ Stem Cells(Miltenyi Biotec) 相关的药物交易